Health ❯ Healthcare ❯ Pharmaceuticals

Drug Pricing

Weight Loss Drugs Medicare Prescription Drugs Weight Loss Medications Pfizer Market Competition Medicare Negotiations Direct-to-Consumer Sales Eli Lilly Generic Drugs

SNL Cold Open Skewers Trump Over Oval Office Collapse, Shutdown Fallout, Rising Prices

The sketch recast a viral Oval Office collapse as commentary on the administration’s handling of the shutdown.

U.S. Strikes Price-Cut Deals With Novo Nordisk and Eli Lilly for GLP‑1s, With Medicare Pilot in 2026

White House Strikes Deals With Lilly and Novo to Cut GLP-1 Prices, Widen Medicare Access

White House Seals Deals With Lilly and Novo to Cut GLP-1 Costs, Pilot Medicare Coverage

Senators Edge Toward 340B Overhaul as CBO Warns on Costs and HRSA Plans 2026 Rebate Pilot

FDA Proposes Faster Biosimilar Approvals by Dropping Routine Human Trials

RFK Jr. To Announce New HHS Plan To Cut U.S. Drug Prices Today

Oz Defends Trump’s Drug-Price Math on NBC as Fact-Checks Reject Claims of Cuts Over 100 Percent

Mark Cuban’s Cost Plus Drugs Joins TrumpRx as Data Partner

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide

Experts Question Impact of Trump’s Drug-Price Deals With Pfizer and AstraZeneca

AstraZeneca Strikes White House Drug-Price Deal, Wins Three-Year Tariff Reprieve

AstraZeneca Signs U.S. Drug-Pricing Deal, Pledges MFN Medicaid Rates and TrumpRx Participation

Sam’s Club Joins Costco in Offering $499 Wegovy and Ozempic

UK Proposes 25% Rise in NICE Threshold to Avert Trump Tariffs

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear

Amgen Launches AmgenNow to Sell Repatha Direct to U.S. Patients at $239 a Month

Colorado Sets First State Drug Price Cap, Limits Enbrel to $600 Per 50 mg Dose

White House Pauses Drug Tariffs as Pfizer Signs On to TrumpRx and MFN Pricing

U.S. Eases Pharma Tariff Threat as Pfizer Agrees to Price Cuts and $70 Billion U.S. Investment